Thor Medical ASA (OSL:TRMED) 5-Year EBITDA Growth Rate : 0.00% (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Thor Medical ASA 5-Year EBITDA Growth Rate?

Thor Medical ASA's EBITDA per Share for the six months ended in Dec. 2024 was kr-0.12.

During the past 3 years, the average EBITDA Per Share Growth Rate was 66.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Thor Medical ASA was 83.30% per year. The lowest was -100.90% per year. And the median was -14.90% per year.

Competitive Comparison of Thor Medical ASA's 5-Year EBITDA Growth Rate

For the Biotechnology subindustry, Thor Medical ASA's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Thor Medical ASA's 5-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Thor Medical ASA's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Thor Medical ASA's 5-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

Thor Medical ASA 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Thor Medical ASA (OSL:TRMED) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Thor Medical ASA 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Thor Medical ASA's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Thor Medical ASA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Thor Medical ASA (OSL:TRMED) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

0R6Y:UK 8NN:Germany

Address

Karenslyst Alle 9C, Oslo, NOR, 0278

Website

https://www.thormedical.no

Thor Medical ASA is a company engaged in producing and supplying of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium (Th-232). The objective of the company is to supply alpha emitters to suppliers and developers of innovative drugs targeting indications of high unmet medical need, including any medical products and equipment, and to run business related thereto or associated therewith.

Thor Medical ASA Headlines

No Headlines